Immediate Impact

1 by Nobel laureates 54 standout
Sub-graph 1 of 24

Citing Papers

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
1 intermediate paper

Works of E. Guffanti being referenced

Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
2009
The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study.
2004

Author Peers

Author Last Decade Papers Cites
E. Guffanti 379 126 47 143 39 785
František Duška 173 177 93 301 66 868
Διαμάντω Αρέθα 109 69 59 121 41 716
Anwarul Haque 212 126 111 51 66 940
Bruno Prata Martinez 177 190 159 166 55 701
Mark Finnis 158 132 53 180 50 775
Masafumi Saito 66 67 22 254 33 683
Alexander H. Flannery 114 65 97 228 80 960
Bruno Simini 265 172 121 205 59 887
Vasiliki Tsolaki 310 91 75 154 67 804
Shouzhen Cheng 127 49 48 52 27 753

All Works

Loading papers...

Rankless by CCL
2026